Understanding Oncolytic Viruses and UB084 for Global Partnership 2025-05-28
This article explores the intersection of virology and oncology, examining how scientists harness viruses' natural abilities to combat cancer. Unibest is pleased to present an oncolytic virus asset, currently in Phase II trials, that is open for global licensing and co-development opportunities.
Read More